These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24350841)

  • 41. The cost-effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy in the treatment of depressive and anxiety disorders during a one-year follow-up.
    Maljanen T; Paltta P; Harkanen T; Virtala E; Lindfors O; Laaksonen MA; Knekt P;
    J Ment Health Policy Econ; 2012 Mar; 15(1):13-23. PubMed ID: 22611089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The direct and indirect costs of employee depression, anxiety, and emotional disorders--an employer case study.
    Johnston K; Westerfield W; Momin S; Phillippi R; Naidoo A
    J Occup Environ Med; 2009 May; 51(5):564-77. PubMed ID: 19369892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Economic cost of visual impairment in Japan.
    Roberts CB; Hiratsuka Y; Yamada M; Pezzullo ML; Yates K; Takano S; Miyake K; Taylor HR
    Arch Ophthalmol; 2010 Jun; 128(6):766-71. PubMed ID: 20547955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Costs of bipolar disorder, depression, schizophrenia and anxiety. The right treatments can have significant positive socio-economic effects].
    Ekman M; Granström O; Omérov S; Jacob J; Landén M
    Lakartidningen; 2014 Aug 20-Sep 2; 111(34-35):1362-4. PubMed ID: 25221832
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical anxiety disorders in the context of cancer: A scoping review of impact on resource use and healthcare costs.
    Shaw J; Pearce A; Lopez AL; Price MA
    Eur J Cancer Care (Engl); 2018 Sep; 27(5):e12893. PubMed ID: 30016004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction in Costs after Treating Comorbid Panic Disorder with Agoraphobia and Generalized Anxiety Disorder.
    Ikic V; Belanger C; Bouchard S; Gosselin P; Langlois F; Labrecque J; Dugas MJ; Marchand A
    J Ment Health Policy Econ; 2017 Mar; 20(1):11-20. PubMed ID: 28418834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The economic burden of depression in 1990.
    Greenberg PE; Stiglin LE; Finkelstein SN; Berndt ER
    J Clin Psychiatry; 1993 Nov; 54(11):405-18. PubMed ID: 8270583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050.
    Png ME; Yoong J; Phan TP; Wee HL
    BMC Public Health; 2016 Feb; 16():153. PubMed ID: 26880337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Economic burden of occupational injury and illness in the United States.
    Leigh JP
    Milbank Q; 2011 Dec; 89(4):728-72. PubMed ID: 22188353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost of illness of the prostate cancer in Japan--a time-trend analysis and future projections.
    Kitazawa T; Matsumoto K; Fujita S; Seto K; Hanaoka S; Hasegawa T
    BMC Health Serv Res; 2015 Oct; 15():453. PubMed ID: 26438194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The non-medical out-of-pocket costs to attend a free anxiety disorders treatment clinic in Australia.
    Anderson R; Wong N; Newby JM; Andrews G
    Australas Psychiatry; 2016 Jun; 24(3):261-3. PubMed ID: 26530347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An examination of the factors that influence costs in medical patients with health anxiety.
    Barrett B; Tyrer P; Tyrer H; Cooper S; Crawford MJ; Byford S
    J Psychosom Res; 2012 Jul; 73(1):59-62. PubMed ID: 22691561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Costs of depression in Catalonia (Spain).
    Salvador-Carulla L; Bendeck M; Fernández A; Alberti C; Sabes-Figuera R; Molina C; Knapp M
    J Affect Disord; 2011 Jul; 132(1-2):130-8. PubMed ID: 21402411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Health care costs associated with depressive and anxiety disorders in primary care.
    Simon G; Ormel J; VonKorff M; Barlow W
    Am J Psychiatry; 1995 Mar; 152(3):352-7. PubMed ID: 7864259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cost of mental disorders in France.
    Chevreul K; Prigent A; Bourmaud A; Leboyer M; Durand-Zaleski I
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):879-86. PubMed ID: 22959739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The economic burden of epilepsy in Korea, 2010.
    Jung J; Seo HY; Kim YA; Oh IH; Lee YH; Yoon SJ
    J Prev Med Public Health; 2013 Nov; 46(6):293-9. PubMed ID: 24349650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The economic burden of personality disorders in mental health care.
    Soeteman DI; Hakkaart-van Roijen L; Verheul R; Busschbach JJ
    J Clin Psychiatry; 2008 Feb; 69(2):259-65. PubMed ID: 18363454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost of stroke in The Netherlands from a societal perspective.
    Evers SM; Engel GL; Ament AJ
    Stroke; 1997 Jul; 28(7):1375-81. PubMed ID: 9227686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Economic and epidemiologic aspects of generalized anxiety disorder: a review of the literature].
    Albarracin G; Rovira J; Carreras L; Rejas J
    Actas Esp Psiquiatr; 2008; 36(3):165-76. PubMed ID: 18478457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The social costs of anxiety disorders.
    Leon AC; Portera L; Weissman MM
    Br J Psychiatry Suppl; 1995 Apr; (27):19-22. PubMed ID: 7794589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.